3. Significant Accounting Policies:
The condensed consolidated financial statements should be read in conjunction with the Company's annual financial statements for the year ended March 31, 2012 prepared in accordance with IFRS applicable to those annual consolidated financial statements. The same accounting policies, presentation and methods of computation have been followed in these condensed consolidated financial statements as were applied in the Company's first annual IFRS consolidated financial statements for the year ended March 31, 2012.
4. Revenue:
For the three months ended December 31, 2012 2011(thousands of $)--------------------------------------------------------------------------------------------------------------------------------------------------------Software licenses 15,369 14,377Professional services 1,433 1,521---------------------------------------------------------------------------- 16,802 15,898--------------------------------------------------------------------------------------------------------------------------------------------------------For the nine months ended December 31, 2012 2011(thousands of $)--------------------------------------------------------------------------------------------------------------------------------------------------------Software licenses 45,302 39,669Professional services 4,039 4,150---------------------------------------------------------------------------- 49,341 43,819--------------------------------------------------------------------------------------------------------------------------------------------------------
5. Research and Development Costs:
For the three months ended December 31, 2012 2011(thousands of $)--------------------------------------------------------------------------------------------------------------------------------------------------------Research and development 3,586 3,104Scientific research and experimental development ("SR&ED") investment tax credits (450) (357)---------------------------------------------------------------------------- 3,136 2,747--------------------------------------------------------------------------------------------------------------------------------------------------------For the nine months ended December 31, 2012 2011(thousands of $)--------------------------------------------------------------------------------------------------------------------------------------------------------Research and development 10,458 8,656Scientific research and experimental development ("SR&ED") investment tax credits (1,397) (1,021)---------------------------------------------------------------------------- 9,061 7,635--------------------------------------------------------------------------------------------------------------------------------------------------------



